News
Hainan tightens oversight of drugs imported for urgent clinical need
AI-assisted summary Written by WellCareChina with AI assistance and checked against the original article.
Hainan’s medical products administration issued a notice on 23 July 2026 on supervising medicines and devices imported for urgent clinical need into the Boao Lecheng pilot zone. Designated hospitals must keep full procurement, storage, use and follow-up records, obtain informed consent that sets out the product’s status and that no equivalent domestic product is available, report adverse events, and follow set rules when patients take products away.
Read the original article Opens the original source in a new tab.
Copyright and re-use
The original article is the authoritative text. This page carries our own summary and a link back; no part of the original is reproduced here.
Source tier B — headline, our own summary and a link back only; no full-text copy.